The Vega team and experts provide analyses of the complete range of economic issues arising in antitrust litigation including market definition and market power, market structure, pricing, profitability, and damages. In addition to litigation support, we have experience providing educational presentations to the Court addressing the anticompetitive effects of monopolization.

Vega’s vast expert network includes numerous academic leaders who are well versed in complex economic issues and specialize in a broad array of industries ranging from health care to agriculture. Our experienced testifying experts use qualitative and quantitative methods to provide theoretical and empirical economic analysis.

Below is a list of example engagements for our Antitrust & Competition practice:

Jose Miguel Abito

Assistant Professor of Business Economics & Public Policy at the Wharton School, University of Pennsylvania

  • Antitrust & Competition
  • Energy, Environment, and Natural Resources
Rajeev Bhattacharya

Visiting Professor of Finance in the Cox School of Business at SMU

  • Securities & Finance
  • Data Science & Statistics
  • Valuation
  • Antitrust & Competition
Farasat Bokhari

Senior Lecturer (Associate Professor) in the School of Economics and Centre for Competition Policy at the University of East Anglia

  • Antitrust & Competition
  • Healthcare & Health Economics
  • Insurance & Risk
John R. Bowblis

Professor of Economics at the Farmer School of Business at Miami University (Ohio)

  • Antitrust & Competition
  • Healthcare & Health Economics
Tim Derdenger

Associate Professor of Marketing and Strategy at Carnegie Mellon's Tepper School of Business

  • Antitrust & Competition
Michael A. Einhorn, Ph.D.

Economic Consultant and Expert Witness

  • Intellectual Property
  • Antitrust & Competition
  • Technology, Internet & Media
Daniel Gottlieb

Assistant Professor of Economics at the Olin Business School at Washington University in St. Louis

  • Antitrust & Competition
  • Insurance & Risk
Sudip Gupta

Associate Professor of Finance at Johns Hopkins Carey Business School

  • Securities & Finance
  • Valuation
  • Corporate Finance
  • FinTech, Blockchain, and Cryptocurrency
  • Antitrust & Competition
Stephen F. Hamilton

Professor of Economics in the Orfalea College of Business at Cal Poly San Luis Obispo

  • Valuation
  • Environmental, Social, and Governance (ESG)
  • Agriculture
  • Antitrust & Competition
  • Energy, Environment, and Natural Resources
Paul Hanouna

Associate Professor in the Department of Finance of the Villanova School of Business at Villanova University

  • Intellectual Property
  • Antitrust & Competition
  • Corporate Finance
  • Securities & Finance
  • Data Science & Statistics
  • Financial Institutions
  • Real Estate
Joseph Harrington

Patrick T. Harker Professor of Business Economics and Public Policy at the Wharton School, University of Pennsylvania

  • Antitrust & Competition
John Kagel

University Chaired Professor of Applied Economics and Director of the Economics Laboratory at the Ohio State University

  • Intellectual Property
  • Technology, Internet & Media
  • Antitrust & Competition
Haim Kassa

Associate Professor of Finance at the Farmer School of Business, Miami University

  • Securities & Finance
  • Antitrust & Competition
  • Data Science & Statistics
  • Financial Institutions
  • Valuation
Yizao Liu

Assistant Professor of Agricultural Economics, Pennsylvania State University

  • Energy, Environment, and Natural Resources
  • Antitrust & Competition
  • Agriculture
Thomas Z. Lys

Eric L. Kohler Professor Emeritus at the Kellogg School of Management, Northwestern University

  • Antitrust & Competition
  • Securities & Finance
  • Accounting
  • Valuation
  • Real Estate
Samir Mamadehussene

Assistant Professor of Marketing in the Naveen Jindal School of Management at UT Dallas

  • Antitrust & Competition
Jon M. Riddle

Principal and Senior Economist at ECONOMIC ASSOCIATES

  • Valuation
  • Healthcare & Health Economics
  • Antitrust & Competition
Louis Rossiter

Research Professor in the Thomas Jefferson Program in Public Policy at William & Mary

  • Antitrust & Competition
  • Healthcare & Health Economics
Daniel F. Spulber

Elinor Hobbs Distinguished Professor of International Business and Professor of Strategy at the Kellogg School of Management, Northwestern University

  • Technology, Internet & Media
  • Antitrust & Competition
  • Intellectual Property
Wei Tan

Managing Director at Mingde Economic Research Inc. and an Adjunct Professor at Johns Hopkins University

  • Data Science & Statistics
  • Valuation
  • Antitrust & Competition
Kosuke Uetake

Associate Professor of Marketing in the Yale University School of Management

  • Marketing
  • Healthcare & Health Economics
  • Antitrust & Competition
Jason Winfree

Associate Professor, Department of Agricultural Economics and Rural Sociology at the University of Idaho

  • Antitrust & Competition
  • Agriculture
Xiaoyong Zheng

Professor of Agricultural and Resource Economics at North Carolina State University

  • Antitrust & Competition
  • Agriculture
Andrew Zuppann

Principal, Vega Economics

  • Labor & Employment
  • Securities & Finance
  • Data Science & Statistics
  • Antitrust & Competition
  • Healthcare & Health Economics
August 18, 2022 | Article
The Key Role Of Economic Analysis In PGA Tour Antitrust Suit (Law360)

The antitrust legal community has been buzzing about the legal battle between the PGA Tour and its players. The article by Dr. Tim Derdenger from Carnegie Mellon University and Alison Palo from Vega Economics, published by Law360, discusses the issues contributing to that legal battle, including the economic factors that will play a role in evaluating the PGA Tour's actions.

August 16, 2022 | News
Technology | Academics | Policy (TAP) Features Professor Daniel Spulber's Study

TAP features a paper, “Measuring the Private and Social Returns to R&D: Unintended Spillovers versus Technology Markets,” by Professors Daniel Spulber and Pere Arque´-Castells establishing the importance of markets for technology for innovation.

July 15, 2022 | News
Antitrust Policy Toward Intermediaries: Digital Platforms and "Big Tech"

This article by expert Dr. Daniel Spulber from Northwestern University considers U.S. and EU antitrust policies regarding intermediaries with digital platforms. The article examines antitrust concerns about "Big Tech." The discussion emphasizes the need to apply advances in the Economics of Markets and Platforms in developing these antitrust policies.

June 27, 2022 | Insights from Experts
Insights with Professor Tim Derdenger: Looming Legal Battles Between PGA and LIV Golf Present Opportunity for Unique Economic Analysis

Following the buzz in the antitrust community about the potential legal battles looming between the PGA and the LIV tour golfers, Vega is thrilled to gain insight on this hot topic from Dr. Tim Derdenger, Associate Professor of Marketing and Strategy at Carnegie Mellon’s Tepper School of Business. 

June 6, 2022 | Article
Antitrust and Innovation Competition, by Daniel F. Spulber, PhD

Expert Dr. Daniel Spulber recently published the article "Antitrust and Innovation Competition" in the Journal of Antitrust Enforcement. The article argues that although antitrust policy makers recognize the importance of innovation competition, they need to update their economic frameworks. Dr. Spulber discusses that antitrust policy makers need to move beyond traditional analysis based on the twin frameworks of perfect competition and imperfect competition. 

May 9, 2022 | News
Measuring the Private and Social Returns to R&D: Unintended Spillovers versus Technology Markets

Prof. Daniel Spulber's paper, Measuring the Private and Social Returns to R&D: Unintended Spillovers versus Technology Markets, was recently accepted by one of the most prestigious journals in economics, Journal of Political Economy.

April 25, 2022 | Featured Expert
Featured Expert: Jon Riddle, PhD

Our featured expert, Jon Riddle, PhD, has worked as a professional economist for over 30 years. Dr. Riddle has provided expert opinions on a wide range of engagements including antitrust, health care, the pharmaceutical industry, and valuation and damages. In a recent case, Vega recently supported Dr. Riddle's profitability analysis of an infusion center. 

March 14, 2022 | Insights from Experts
Prof. Daniel Spulber Weighs in on Draft SEP Policy Statement

Prof. Daniel Spulber joined more than 150 public comments that were submitted to weigh in on the Draft Revised Statement on remedies for the infringement of standards-essential patents (or SEPs) that are subject to a RAND or F/RAND licensing commitment. 

November 26, 2021 | Featured Engagement
Featured Engagement: Analysis of Pricing Pressure and Price Fixing in Generic Drug Market

Vega was retained by a group of major hedge funds as opt-out plaintiffs in several securities class actions to support Professor Lou Rossiter in analyzing issues related to pricing pressures and price fixing for certain drugs in the generic drug market.

November 12, 2021 | Article
Structural Factors that Facilitate Anticompetitive Behavior: Providing a Useful Context in Antitrust Cases

Certain structural factors, when present in a given market, can facilitate anticompetitive behavior. In this article, we discuss ten factors that provide a useful starting point for contextualizing the competitive environment of a given market and providing a general framework within which to evaluate the specific data related to that market. 

September 6, 2021 | Brochure
Navigating Economic Issues With Insight from Leading Antitrust Experts

This brochure highlights Vega's leading experts in antitrust litigation who can offer opinions on market definition and market power, market structure, pricing, profitability, and damages.

August 23, 2021 | Article
The Modern Regulatory Framework for Generic Drugs Encourages Active Price Competition

The regulatory framework for pharmaceuticals has evolved alongside this boom to facilitate the safe and affordable access to medicine as consumers increase their use of generics. This article reviews the historical development of the regulatory framework for generic pharmaceuticals in the U.S. and its economic impact, particularly in facilitating price competition.

August 2, 2021 | Insights from Experts
Insights from Professor Spulber Regarding the Executive Order on Antitrust

President Biden's recent Executive Order announced a government-wide effort to fight overconcentration, monopolization, and unfair competition. To unpack the implications of this Order, Vega interviews Professor Daniel Spulber, who shares his insights about what businesses should be thinking about in light of this Order and how economic analysis can help evaluate its implications. 

June 25, 2021 | Featured Expert
Dr. Daniel Spulber, Elinor Hobbs Distinguished Professor of International Business and Professor of Strategy, Northwestern University

Vega’s recently welcomed Dr. Daniel Spulber to our expert network. Dr. Spulber is an expert in antitrust, platforms and two-sided markets, intellectual property, technology and innovation, and industrial organization.

June 7, 2021 | Featured Expert
Dr. Thomas Lys, Eric L. Kohler Professor Emeritus at the Kellogg School of Management, Northwestern University

Our featured expert, Dr. Thomas Lys is is an expert in areas including accounting, corporate finance, corporate governance, real estate, and finance. Dr. Lys was recently supported by Vega to rebut plaintiffs’ damages calculations in seven cases brought against RMBS servicers and master servicers.

May 7, 2021 | Featured Expert
Dr. Haim Kassa, Associate Professor of Finance at the Farmer School of Business, Miami University

Our featured expert, Haim Kassa, is is an expert in the areas of investments and portfolio management and he is experienced in the design and testing of trading strategies using historical firm level data from the stock, bond, and option markets.

March 25, 2021 | Featured Expert
Dr. Lou Rossiter, Research Professor, Program in Public Policy, William & Mary

Our featured expert, Lou Rossiter, is an expert in health economics. He has served as an expert on numerous cases and most recently he has been retained with the support of the Vega team to provide an analysis of pricing pressure and price fixing in the generic drug market for certain drugs.

January 4, 2021 | Article
Facebook Litigation: Threshold Questions and Antitrust Analyses

Vega discusses the threshold questions that will need to be answered in the antitrust analyses of the recent Facebook cases brought by the FTC and attorney general from numerous states.

February 7, 2019 | Brochure
Antitrust and Competition Capabilities

The Vega team and experts provide analyses of the complete range of economic issues arising in antitrust litigation including market definition and market power, market structure, pricing, profitability, and damages. This publication highlights Vega's antitrust practice, explaining both our significant experience with antitrust engagements and some of the qualifications of our antitrust experts.